{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:14:17Z","timestamp":1791947657381,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T00:00:00Z","timestamp":1459555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T00:00:00Z","timestamp":1459555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11940-016-0404-7","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T02:49:29Z","timestamp":1459565369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Myoclonus: Pathophysiology and Treatment Options"],"prefix":"10.1007","volume":"18","author":[{"given":"Ariel","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,2]]},"reference":[{"key":"404_CR1","first-page":"447","volume-title":"Myoclonus: phenomenology, etiology, physiology, and treatment principles and practice of movement disorders","author":"JJ Stanley Fahn","year":"2011","unstructured":"Stanley Fahn JJ, Hallett M. Myoclonus: phenomenology, etiology, physiology, and treatment principles and practice of movement disorders. Edinburgh: Saunders; 2011. p. 447\u201364."},{"key":"404_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1212\/WNL.40.10.1561","volume":"40","author":"A Ikeda","year":"1990","unstructured":"Ikeda A, Kakigi R, Funai N, et al. Cortical tremor: a variant of cortical reflex myoclonus. Neurology. 1990;40:1561\u20135.","journal-title":"Neurology"},{"key":"404_CR3","volume-title":"Principles and practice of movement disorders","author":"JJ Stanley Fahn","year":"2011","unstructured":"Stanley Fahn JJ, Hallett M. Principles and practice of movement disorders. Edinburgh: Saunders; 2011."},{"key":"404_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","volume":"3","author":"JN Caviness","year":"2004","unstructured":"Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol. 2004;3:598\u2013607.","journal-title":"Lancet Neurol"},{"key":"404_CR5","first-page":"1264","volume":"19","author":"AJ Espay","year":"2013","unstructured":"Espay AJ, Chen R. Myoclonus. Continuum (Minneap Minn). 2013;19:1264\u201386. This review focuses on the etiology, diagnosis, and electrophysiological evaluation of myoclonus as well as treatment.","journal-title":"Continuum (Minneap Minn)"},{"key":"404_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1001\/archneurol.2009.299","volume":"67","author":"M Kurian","year":"2010","unstructured":"Kurian M, Lalive PH, Dalmau JO, et al. Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis. Arch Neurol. 2010;67:118\u201321.","journal-title":"Arch Neurol"},{"key":"404_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1212\/WNL.0b013e318227b176","volume":"77","author":"MR Turner","year":"2011","unstructured":"Turner MR, Irani SR, Leite MI, et al. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology. 2011;77:439\u201343.","journal-title":"Neurology"},{"key":"404_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1081\/CNV-120030214","volume":"22","author":"R Erlich","year":"2004","unstructured":"Erlich R, Morrison C, Kim B, et al. ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features\u2014correlation of clinical improvement with tumor response. Cancer Investig. 2004;22:257\u201361.","journal-title":"Cancer Investig"},{"key":"404_CR9","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/B978-0-444-52910-7.00042-8","volume":"112","author":"M Pike","year":"2013","unstructured":"Pike M. Opsoclonus-myoclonus syndrome. Handb Clin Neurol. 2013;112:1209\u201311.","journal-title":"Handb Clin Neurol"},{"key":"404_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/mds.25867","volume":"29","author":"C Ganos","year":"2014","unstructured":"Ganos C, Kassavetis P, Erro R, et al. The role of the cerebellum in the pathogenesis of cortical myoclonus. Mov Disord. 2014;29:437\u201343.","journal-title":"Mov Disord"},{"key":"404_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.58.6.745","volume":"58","author":"K Terada","year":"1995","unstructured":"Terada K, Ikeda A, Van Ness PC, et al. Presence of bereitschaftspotential preceding psychogenic myoclonus: clinical application of jerk-locked back averaging. J Neurol Neurosurg Psychiatry. 1995;58:745\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"404_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1212\/WNL.0b013e3181a0fd50","volume":"72","author":"E Roze","year":"2009","unstructured":"Roze E, Bounolleau P, Ducreux D, et al. Propriospinal myoclonus revisited: clinical, neurophysiologic, and neuroradiologic findings. Neurology. 2009;72:1301\u20139. Article summarizes the clinical, electrophysiological, and neuroimaging features of propriosimal myoclonus. They report microstructual injuries that may explain some idiopathic cases.","journal-title":"Neurology"},{"key":"404_CR13","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1212\/WNL.0000000000000982","volume":"83","author":"SM van der Salm","year":"2014","unstructured":"van der Salm SM, Erro R, Cordivari C, et al. Propriospinal myoclonus: clinical reappraisal and review of literature. Neurology. 2014;83:1862\u201370.","journal-title":"Neurology"},{"key":"404_CR14","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/jnnp-2012-303081","volume":"83","author":"SM van der Salm","year":"2012","unstructured":"van der Salm SM, Tijssen MA, Koelman JH, et al. The bereitschaftspotential in jerky movement disorders. J Neurol Neurosurg Psychiatry. 2012;83:1162\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"404_CR15","volume-title":"Handbook of clinical neurophysiology","author":"JN Caviness","year":"2003","unstructured":"Caviness JN. The clinical neurophysiology of myoclonus. In: Hallet M, editor. Handbook of clinical neurophysiology. Amsterdam: Elsevier; 2003."},{"key":"404_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.sleep.2014.01.024","volume":"15","author":"G Calandra-Buonaura","year":"2014","unstructured":"Calandra-Buonaura G, Alessandria M, Liguori R, et al. Hypnic jerks: neurophysiological characterization of a new motor pattern. Sleep Med. 2014;15:725\u20137.","journal-title":"Sleep Med"},{"key":"404_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/B978-0-444-52014-2.00031-8","volume":"100","author":"JN Caviness","year":"2011","unstructured":"Caviness JN, Truong DD. Myoclonus. Handb Clin Neurol. 2011;100:399\u2013420.","journal-title":"Handb Clin Neurol"},{"key":"404_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ncl.2011.08.002","volume":"29","author":"MJ Angel","year":"2011","unstructured":"Angel MJ, Young GB. Metabolic encephalopathies. Neurol Clin. 2011;29:837\u201382.","journal-title":"Neurol Clin"},{"key":"404_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00023210-200418020-00003","volume":"18","author":"FJ Jimenez-Jimenez","year":"2004","unstructured":"Jimenez-Jimenez FJ, Puertas I, de Toledo-Heras M. Drug-induced myoclonus: frequency, mechanisms and management. CNS Drugs. 2004;18:93\u2013104.","journal-title":"CNS Drugs"},{"key":"404_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1017\/S0317167100018229","volume":"39","author":"AF Deik","year":"2012","unstructured":"Deik AF, Shanker VL. A case of amiodarone-associated myoclonus responsive to levetiracetam. Can J Neurol Sci. 2012;39:680\u20131.","journal-title":"Can J Neurol Sci"},{"key":"404_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/mds.870080112","volume":"8","author":"P Brown","year":"1993","unstructured":"Brown P, Steiger MJ, Thompson PD, et al. Effectiveness of piracetam in cortical myoclonus. Mov Disord. 1993;8:63\u20138.","journal-title":"Mov Disord"},{"key":"404_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00002826-198812000-00006","volume":"11","author":"JA Obeso","year":"1988","unstructured":"Obeso JA, Artieda J, Quinn N, et al. Piracetam in the treatment of different types of myoclonus. Clin Neuropharmacol. 1988;11:529\u201336.","journal-title":"Clin Neuropharmacol"},{"key":"404_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/jnnp.64.3.344","volume":"64","author":"M Koskiniemi","year":"1998","unstructured":"Koskiniemi M, Van Vleymen B, Hakamies L, et al. Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. J Neurol Neurosurg Psychiatry. 1998;64:344\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"404_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3109\/00207454.2013.866951","volume":"124","author":"GK Mbizvo","year":"2014","unstructured":"Mbizvo GK, Dixon P, Hutton JL, et al. The adverse effects profile of levetiracetam in epilepsy: a more detailed look. Int J Neurosci. 2014;124:627\u201334.","journal-title":"Int J Neurosci"},{"key":"404_CR25","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/mds.20530","volume":"20","author":"P Striano","year":"2005","unstructured":"Striano P, Manganelli F, Boccella P, et al. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord. 2005;20:1610\u20134.","journal-title":"Mov Disord"},{"key":"404_CR26","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/mds.20605","volume":"20","author":"SJ Frucht","year":"2005","unstructured":"Frucht SJ, Bordelon Y, Houghton WH, et al. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord. 2005;20:1330\u20137.","journal-title":"Mov Disord"},{"key":"404_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1684\/j.1950-6945.2000.tb00445.x","volume":"2","author":"P Genton","year":"2000","unstructured":"Genton P, Gelisse P. Antimyoclonic effect of levetiracetam. Epileptic Disord. 2000;2:209\u201312.","journal-title":"Epileptic Disord"},{"key":"404_CR28","unstructured":"Lexicomp Online\u00ae. Accessed October 17th, 2015."},{"key":"404_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.5535\/arm.2012.36.4.561","volume":"36","author":"JH Shin","year":"2012","unstructured":"Shin JH, Park JM, Kim AR, et al. Lance-Adams syndrome. Ann Rehabil Med. 2012;36:561\u20134.","journal-title":"Ann Rehabil Med"},{"key":"404_CR30","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1212\/01.wnl.0000188670.38576.bd","volume":"65","author":"SJ Frucht","year":"2005","unstructured":"Frucht SJ, Houghton WC, Bordelon Y, et al. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology. 2005;65:1967\u20139.","journal-title":"Neurology"},{"key":"404_CR31","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1001\/jama.1981.03310490013011","volume":"245","author":"MK Menon","year":"1981","unstructured":"Menon MK. Antimyoclonic effect of sodium oxybate: clinical implications. JAMA. 1981;245:2495.","journal-title":"JAMA"},{"key":"404_CR32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0310057X0903700214","volume":"37","author":"R Arpesella","year":"2009","unstructured":"Arpesella R, Dallocchio C, Arbasino C, et al. A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate. Anaesth Intensive Care. 2009;37:314\u20138.","journal-title":"Anaesth Intensive Care"},{"key":"404_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1600-0404.1978.tb04502.x","volume":"57","author":"I Magnussen","year":"1978","unstructured":"Magnussen I, Dupont E, Engbaek F, et al. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. Acta Neurol Scand. 1978;57:289\u201394.","journal-title":"Acta Neurol Scand"},{"key":"404_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1212\/WNL.25.2.135","volume":"25","author":"MH Van Woert","year":"1975","unstructured":"Van Woert MH, Sethy VH. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Neurology. 1975;25:135\u201340.","journal-title":"Neurology"},{"key":"404_CR35","first-page":"115","volume":"89","author":"G Deuschl","year":"2002","unstructured":"Deuschl G, Wilms H. Palatal tremor: the clinical spectrum and physiology of a rhythmic movement disorder. Adv Neurol. 2002;89:115\u201330.","journal-title":"Adv Neurol"},{"key":"404_CR36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/brain\/awh684","volume":"129","author":"C Zadikoff","year":"2006","unstructured":"Zadikoff C, Lang AE, Klein C. The \u2018essentials\u2019 of essential palatal tremor: a reappraisal of the nosology. Brain. 2006;129:832\u201340.","journal-title":"Brain"},{"key":"404_CR37","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/mds.24948","volume":"27","author":"M Stamelou","year":"2012","unstructured":"Stamelou M, Saifee TA, Edwards MJ, et al. Psychogenic palatal tremor may be underrecognized: reappraisal of a large series of cases. Mov Disord. 2012;27:1164\u20138.","journal-title":"Mov Disord"},{"key":"404_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/mds.26226","volume":"30","author":"DS Kern","year":"2015","unstructured":"Kern DS, Lang AE. Successful treatment of functional palatal tremor: insights into pathogenesis and management. Mov Disord. 2015;30:875\u20136. This report highlights the evolving understanding of essential palatal tremor (myoclonus) and its functional etiology.","journal-title":"Mov Disord"},{"key":"404_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1053\/seiz.2002.0592","volume":"11","author":"A Nasr","year":"2002","unstructured":"Nasr A, Brown N. Palatal myoclonus responding to lamotrigine. Seizure. 2002;11:136\u20137.","journal-title":"Seizure"},{"key":"404_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00415-006-0039-9","volume":"253","author":"SE Penney","year":"2006","unstructured":"Penney SE, Bruce IA, Saeed SR. Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature. J Neurol. 2006;253:857\u201360.","journal-title":"J Neurol"},{"key":"404_CR41","first-page":"253","volume":"3","author":"JA Obeso","year":"1995","unstructured":"Obeso JA. Therapy of myoclonus. Clin Neurosci. 1995;3:253\u20137.","journal-title":"Clin Neurosci"},{"key":"404_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/jnnp.73.4.457","volume":"73","author":"SC Keswani","year":"2002","unstructured":"Keswani SC, Kossoff EH, Krauss GL, et al. Amelioration of spinal myoclonus with levetiracetam. J Neurol Neurosurg Psychiatry. 2002;73:457\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"404_CR43","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/mds.20217","volume":"19","author":"A Siniscalchi","year":"2004","unstructured":"Siniscalchi A, Mancuso F, Russo E, et al. Spinal myoclonus responsive to topiramate. Mov Disord. 2004;19:1380\u20131.","journal-title":"Mov Disord"},{"key":"404_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1179\/2045772311Y.0000000006","volume":"35","author":"AE Chiodo","year":"2012","unstructured":"Chiodo AE, Saval A. Intrathecal baclofen for the treatment of spinal myoclonus: a case series. J Spinal Cord Med. 2012;35:64\u20137.","journal-title":"J Spinal Cord Med"},{"key":"404_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/mds.870090221","volume":"9","author":"KB Polo","year":"1994","unstructured":"Polo KB, Jabbari B. Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin. Mov Disord. 1994;9:233\u20135.","journal-title":"Mov Disord"},{"key":"404_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/1531-8257(199901)14:1<182::AID-MDS1040>3.0.CO;2-8","volume":"14","author":"A Lagueny","year":"1999","unstructured":"Lagueny A, Tison F, Burbaud P, et al. Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A. Mov Disord. 1999;14:182\u20135.","journal-title":"Mov Disord"},{"key":"404_CR47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.33588\/rn.4201.2005500","volume":"42","author":"F Vivancos-Matellano","year":"2006","unstructured":"Vivancos-Matellano F, Arpa-Gutierrez FJ, Perez-Conde MC, et al. The effectiveness of Botulinum toxin type A in two cases of abdominal myoclonias refractory to conventional therapy. Rev Neurol. 2006;42:59\u201361.","journal-title":"Rev Neurol"},{"key":"404_CR48","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/mds.25951","volume":"29","author":"M Esposito","year":"2014","unstructured":"Esposito M, Erro R, Edwards MJ, et al. The pathophysiology of symptomatic propriospinal myoclonus. Mov Disord. 2014;29:1097\u20139.","journal-title":"Mov Disord"},{"key":"404_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smrv.2014.10.007","volume":"22","author":"E Antelmi","year":"2015","unstructured":"Antelmi E, Provini F. Propriospinal myoclonus: the spectrum of clinical and neurophysiological phenotypes. Sleep Med Rev. 2015;22:54\u201363.","journal-title":"Sleep Med Rev"},{"key":"404_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2011.09.036","volume":"313","author":"W Jang","year":"2012","unstructured":"Jang W, Kim JS, Ahn JY, et al. Reversible propriospinal myoclonus due to thoracic disc herniation: long-term follow-up. J Neurol Sci. 2012;313:32\u20134.","journal-title":"J Neurol Sci"},{"key":"404_CR51","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/mds.10453","volume":"18","author":"AJ Espay","year":"2003","unstructured":"Espay AJ, Ashby P, Hanajima R, et al. Unique form of propriospinal myoclonus as a possible complication of an enteropathogenic toxin. Mov Disord. 2003;18:942\u20138.","journal-title":"Mov Disord"},{"key":"404_CR52","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/mds.25627","volume":"28","author":"R Erro","year":"2013","unstructured":"Erro R, Bhatia KP, Edwards MJ, et al. Clinical diagnosis of propriospinal myoclonus is unreliable: an electrophysiologic study. Mov Disord. 2013;28:1868\u201373. This article highlights that propriospinal myoclonus requires electrophysiological characterization and posists that the etiology in most cases may be functional.","journal-title":"Mov Disord"},{"key":"404_CR53","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/mds.22315","volume":"23","author":"D Maltete","year":"2008","unstructured":"Maltete D, Verdure P, Roze E, et al. TENS for the treatment of propriospinal myoclonus. Mov Disord. 2008;23:2256\u20137.","journal-title":"Mov Disord"},{"key":"404_CR54","unstructured":"Hallett M. Psychogenic movement disorders: neurology and neuropsychiatry. Wolters Kluwer; 2005."},{"key":"404_CR55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5334\/tohm.266","volume":"5","author":"JF Baizabal-Carvallo","year":"2015","unstructured":"Baizabal-Carvallo JF, Fekete R. Recognizing uncommon presentations of psychogenic (functional) movement disorders. Tremor Other Hyperkinet Mov (N Y). 2015;5:279.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"404_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2013.09.018","volume":"20","author":"K Kompoliti","year":"2014","unstructured":"Kompoliti K, Wilson B, Stebbins G, et al. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord. 2014;20:60\u20133. This article is a well designed randomized cross-over study that demonstrates that patients kept within the medical system and regularly evaluated by physicians with or without psychodynamic therapy can help treat functional movement disorders.","journal-title":"Parkinsonism Relat Disord"},{"key":"404_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.parkreldis.2005.10.006","volume":"12","author":"VK Hinson","year":"2006","unstructured":"Hinson VK, Weinstein S, Bernard B, et al. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006;12:177\u201380.","journal-title":"Parkinsonism Relat Disord"},{"key":"404_CR58","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.parkreldis.2011.10.011","volume":"18","author":"K Czarnecki","year":"2012","unstructured":"Czarnecki K, Thompson JM, Seime R, et al. Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord. 2012;18:247\u201351.","journal-title":"Parkinsonism Relat Disord"},{"key":"404_CR59","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mds.22952","volume":"25","author":"C Dallocchio","year":"2010","unstructured":"Dallocchio C, Arbasino C, Klersy C, et al. The effects of physical activity on psychogenic movement disorders. Mov Disord. 2010;25:421\u20135.","journal-title":"Mov Disord"},{"key":"404_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2340\/16501977-1246","volume":"46","author":"AA Jordbru","year":"2014","unstructured":"Jordbru AA, Smedstad LM, Klungsoyr O, et al. Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med. 2014;46:181\u20137.","journal-title":"J Rehabil Med"},{"key":"404_CR61","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/jnnp-2011-302147","volume":"83","author":"MJ Edwards","year":"2012","unstructured":"Edwards MJ, Stone J, Nielsen G. Physiotherapists and patients with functional (psychogenic) motor symptoms: a survey of attitudes and interest. J Neurol Neurosurg Psychiatry. 2012;83:655\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"404_CR62","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1212\/WNL.0b013e3181d55f24","volume":"74","author":"TA Zesiewicz","year":"2010","unstructured":"Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:924\u201331.","journal-title":"Neurology"},{"key":"404_CR63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000315464","volume":"88","author":"K Kobayashi","year":"2010","unstructured":"Kobayashi K, Katayama Y, Otaka T, et al. Thalamic deep brain stimulation for the treatment of action myoclonus caused by perinatal anoxia. Stereotact Funct Neurosurg. 2010;88:259\u201363.","journal-title":"Stereotact Funct Neurosurg"},{"key":"404_CR64","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/WNL.0b013e31821482f4","volume":"76","author":"K Yamada","year":"2011","unstructured":"Yamada K, Sakurama T, Soyama N, et al. Gpi pallidal stimulation for Lance-Adams syndrome. Neurology. 2011;76:1270\u20132.","journal-title":"Neurology"},{"key":"404_CR65","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/mds.1119","volume":"16","author":"T Trottenberg","year":"2001","unstructured":"Trottenberg T, Meissner W, Kabus C, et al. Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome. Mov Disord. 2001;16:769\u201371.","journal-title":"Mov Disord"},{"key":"404_CR66","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archneurol.2010.338","volume":"68","author":"J Azoulay-Zyss","year":"2011","unstructured":"Azoulay-Zyss J, Roze E, Welter ML, et al. Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to epsilon-sarcoglycan mutations: a pilot study. Arch Neurol. 2011;68:94\u20138.","journal-title":"Arch Neurol"},{"key":"404_CR67","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1136\/jnnp.2004.039248","volume":"76","author":"CM Magarinos-Ascone","year":"2005","unstructured":"Magarinos-Ascone CM, Regidor I, Martinez-Castrillo JC, et al. Pallidal stimulation relieves myoclonus-dystonia syndrome. J Neurol Neurosurg Psychiatry. 2005;76:989\u201391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"404_CR68","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/B978-0-444-53497-2.00016-4","volume":"116","author":"PA Starr","year":"2013","unstructured":"Starr PA. Deep brain stimulation for other tremors, myoclonus, and chorea. Handb Clin Neurol. 2013;116:209\u201315.","journal-title":"Handb Clin Neurol"},{"key":"404_CR69","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/mds.25326","volume":"28","author":"AI Rughani","year":"2013","unstructured":"Rughani AI, Lozano AM. Surgical treatment of myoclonus dystonia syndrome. Mov Disord. 2013;28:282\u20137. This review of published cases compared different targets for functional neurosurgery in myoclonus dystonia syndrome. Both dystonia and myoclonus improved in their analysis. Globus pallidus targets improved dystonia to a greater extent than the thalamic one.","journal-title":"Mov Disord"},{"key":"404_CR70","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.parkreldis.2014.04.017","volume":"20","author":"C Sidiropoulos","year":"2014","unstructured":"Sidiropoulos C, Mestre T, Hutchison W, et al. Bilateral pallidal stimulation for sargoglycan epsilon negative myoclonus. Parkinsonism Relat Disord. 2014;20:915\u20138.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-016-0404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-016-0404-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-016-0404-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-016-0404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:41:01Z","timestamp":1748832061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-016-0404-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,2]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["404"],"URL":"https:\/\/doi.org\/10.1007\/s11940-016-0404-7","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,2]]},"assertion":[{"value":"2 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ariel Levy declares no conflict of interest.Robert Chen received research grant from Medtronic Inc, honorarium from Allergan, and research grant and honorarium from Merz.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"21"}}